Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening

Overview

About this study

The purpose of this study is to evaluate and compare the effectiveness of active screening for SHD in asymptomatic outpatients referred for an ECG, using a combination of AI-ECG and FOCUS. Invites will be sent and participants enrolled electronically.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adult patients (> 18 years of age)
  • Echocardiogram is not clinically indicated.

Exclusion Criteria: 

  • Prior history of SHD, (e.g., heart failure, reduced left ventricular ejection fraction, aortic stenosis, cardiac amyloidosis, or hypertrophic cardiomyopathy)
  • Recent (within last 12 months) echocardiogram.
  • Scheduled future echocardiogram.
  • Inability to provide informed consent to participate in the study.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 1/22/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Gal Tsaban, M.D., Ph.D.

Open for enrollment

Contact information:

Structural Heart Disease Research Coordinators

(507) 255-6133

More information

Publications

Publications are currently not available